The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Paggiarino Dario A. since 2018.
This trader's CIK number is 1574261.
At the time of last reporting, Paggiarino Dario A. was the Chief Medical Officer of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | EYPT | 0 | $0 | 89,224 | $2,168,130 | 165,713 | $939,607 |
| 2023 | EYPT | 0 | $0 | 32,083 | $702,910 | 42,883 | $325,000 |
| 2022 | EYPT | 0 | $0 | 0 | $0 | 4,105 | $0 |
| 2021 | EYPT | 0 | $0 | 0 | $0 | 5,525 | $0 |
| 2020 | EYPT | 0 | $0 | 0 | $0 | 65,250 | $0 |
| 2019 | EYPT | 0 | $0 | 0 | $0 | 24,200 | $0 |
| 2018 | EYPT | 0 | $0 | 0 | $0 | 10,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-30 | EYPT | Option Ex | 50,404 | .00 | 0 |
| 2024-02-09 | EYPT | Option Ex | 10,800 | .00 | 0 |
| 2024-01-26 | EYPT | Option Ex | 49,325 | 13.05 | 643,839 |
| 2024-01-26 | EYPT | Sale | 49,325 | 25.53 | 1,259,217 |
| 2024-01-25 | EYPT | Option Ex | 600 | 13.02 | 7,809 |
| 2024-01-25 | EYPT | Sale | 600 | 25.00 | 15,000 |
| 2024-01-24 | EYPT | Sale | 11,251 | 25.01 | 281,410 |
| 2024-01-23 | EYPT | Sale | 5,135 | 25.00 | 128,375 |
| 2024-01-24 | EYPT | Option Ex | 11,251 | 13.02 | 146,431 |
| 2024-01-23 | EYPT | Option Ex | 5,135 | 13.02 | 66,832 |
| 2024-01-08 | EYPT | Option Ex | 22,913 | 3.26 | 74,696 |
| 2024-01-08 | EYPT | Sale | 22,913 | 21.13 | 484,128 |
| 2024-01-06 | EYPT | Option Ex | 15,285 | .00 | 0 |
| 2023-12-13 | EYPT | Option Ex | 1,458 | 10.13 | 14,769 |
| 2023-12-13 | EYPT | Sale | 1,458 | 20.00 | 29,160 |
| 2023-12-04 | EYPT | Option Ex | 30,625 | 10.13 | 310,231 |
| 2023-12-04 | EYPT | Sale | 30,625 | 22.00 | 673,750 |
| 2023-02-09 | EYPT | Option Ex | 10,800 | .00 | 0 |
| 2022-02-28 | EYPT | Option Ex | 4,105 | .00 | 0 |
| 2021-06-14 | EYPT | Option Ex | 1,420 | .00 | 0 |
| 2021-02-28 | EYPT | Option Ex | 4,105 | .00 | 0 |
| 2020-06-30 | EYPT | Option Ex | 41,050 | .00 | 0 |
| 2020-06-27 | EYPT | Option Ex | 10,000 | .00 | 0 |
| 2020-06-14 | EYPT | Option Ex | 14,200 | .00 | 0 |
| 2019-06-27 | EYPT | Option Ex | 10,000 | .00 | 0 |
| 2019-06-14 | EYPT | Option Ex | 14,200 | .00 | 0 |
| 2018-06-27 | EYPT | Option Ex | 10,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Paggiarino Dario A. (Chief Medical Officer of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.